Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Supreme Court
Pharma
Supreme Court rejects Vanda's Hetlioz patent revival appeal
The U.S. Supreme Court has rebuffed Vanda's bid to revive patents on its 10-year-old sleep disorder drug Hetlioz following a 2023 appeals court loss.
Fraiser Kansteiner
Apr 22, 2024 3:49pm
Supreme Court hears oral arguments around medication abortion
Mar 26, 2024 11:21am
SCOTUS agrees to hear abortion pill restriction case
Dec 13, 2023 1:08pm
US lawyer urges Supreme Court to overturn mifepristone verdict
Nov 27, 2023 3:39pm
Industry players urge SCOTUS to overturn abortion pill ruling
Oct 17, 2023 11:20am
Danco wants Supreme Court to reverse a mifepristone ruling
Sep 8, 2023 3:34pm